Related Experiment Video
Updated: Jul 12, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Kidney and Cardiovascular Outcomes by Chronic Kidney Disease Stage and Etiology of Chronic Kidney Disease: A Randomly
Ryoya Tsunoda1, Tomohiro Ohigashi2, Junichi Hoshino3
1Department of Nephrology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Insights
Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease, but polycystic kidney disease (PKD) most frequently leads to dialysis in advanced stages. Non-proteinuric nephrosclerosis (NSc) shows a low risk for end-stage kidney disease.
Area of Science:
- Nephrology
- Chronic Kidney Disease Epidemiology
- Public Health
Background:
- Kidney disease management is a global health priority.
- Identifying primary causes of end-stage kidney disease (ESKD) is crucial for effective interventions.
Purpose of the Study:
- To investigate the primary etiologies of chronic kidney disease (CKD) in a Japanese cohort.
- To analyze the progression rates and outcomes associated with different CKD etiologies.
Main Methods:
- Established the nationwide REACH-J chronic kidney disease (CKD) cohort.
- Enrolled 2,249 patients with CKD stages G3b-G5 across 31 institutions.
- Collected data on lifestyle, medical history, and followed patients for 5 years.
Main Results:
- Diabetic kidney disease (DKD) was the most common etiology (24.5%), followed by nephrosclerosis (NSc; 24.4%).
- Kidney replacement therapy (KRT) initiation rates were highest for DKD in early stages (G3b) and for polycystic kidney disease (PKD) in advanced stages (G4/G5).
- NSc showed consistently low KRT initiation rates, and higher proteinuria predicted poorer renal outcomes.
Conclusions:
- While DKD is the leading cause of ESKD globally, PKD drives dialysis initiation in advanced CKD stages 4-5.
- Non-proteinuric NSc demonstrates a very low risk of ESKD progression, even in advanced CKD stages (G3b-G5).
Introduction:
Kidney disease is a global health priority. Accurate identification of primary diseases causing end-stage kidney disease is essential.
Methods:
We established the REACH-J cohort, a nationwide prospective cohort of patients with advanced chronic kidney disease (CKD) under nephrologist care, using random sampling across 31 institutions. Patients with CKD stages G3b-G5 completed lifestyle and medical surveys; institutions provided medical history data over 5 years of follow-up.
Results:
Among 2,249 patients (mean age, 69.1 ± 12.6 years), primary CKD etiologies were diabetic kidney disease (DKD; 24.5%), nephrosclerosis (NSc; 24.4%), polycystic kidney disease (PKD; 5.8%), and others (45.3%). Event rates (per 100 person-years) were 3.0 for all-cause mortality, 2.0 for pre-kidney replacement therapy (KRT) death, and 8.4 for KRT initiation. Among patients at stage G3b at enrollment, the primary disease most frequently associated with KRT initiation was diabetes. However, among patients at stage G4 or G5 at enrollment, the condition most frequently associated with KRT initiation was PKD. NSc had the lowest KRT initiation rate. Mortality was highest in stage G3b DKD, followed by NSc. Kaplan-Meier analysis showed early KRT initiation in DKD, later surpassed by PKD. Across etiologies, higher proteinuria predicted poorer renal outcomes, whereas cardiovascular and mortality rates did not differ by proteinuria stage.
Conclusions:
Although DKD is the leading cause of end-stage kidney disease worldwide, PKD most commonly leads to dialysis in patients with CKD stages 4-5 under the nephrologist's control. In contrast, non-proteinuric NSc conferred a very low risk of end-stage kidney disease, even in advanced CKD (G3b-G5).
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Kidney Transplant I: Introduction